At the news
? NEUTRALIMPACT 2/10 6-K filed Sep 9, 2026 at 06:00 ET
Novo Nordisk filed a routine 6-K reporting weekly share repurchase activity under its existing DKK 15 billion buyback program. The company repurchased ~1.06M B shares for ~DKK 314.1M during the week of August 31–September 4, 2026, at an average price of ~DKK 297.5 per share. This is a standard periodic disclosure with no new material information, the buyback was announced months ago and is proceeding as planned.
- Novo Nordisk repurchased 1,055,000 B shares during August 31–September 4, 2026, for a total transaction value of approximately DKK 314.1 million.
- Accumulated repurchases under the program initiated May 6, 2026: 17,275,000 B shares for approximately DKK 5.22 billion.
- Total repurchases since the broader 12-month program began February 4, 2026: 32,034,179 B shares for approximately DKK 9.02 billion, at an average price of DKK 281.63 per share.
- Novo Nordisk now holds 46,074,876 B shares as treasury shares, representing 1.0% of total share capital of 4,465,000,000 A and B shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access